Marcus & Millichap's 15min chart shows bullish signs with KDJ Golden Cross and Bullish Marubozu.

Based on Marcus & Millichap's 15-minute chart, a significant technical indicator, the KDJ Golden Cross, has been triggered. This bullish signal, combined with a Bullish Marubozu at 09/08/2025 12:45, indicates a shift in the momentum of the stock price towards the upside. As a result, the potential for further price appreciation is substantial. The market is currently being controlled by buyers, and this bullish momentum is likely to persist.

Based on Marcus & Millichap's 15-minute chart, a significant technical indicator, the KDJ Golden Cross, has been triggered. This bullish signal, combined with a Bullish Marubozu at 09/08/2025 12:45, indicates a shift in the momentum of the stock price towards the upside. As a result, the potential for further price appreciation is substantial. The market is currently being controlled by buyers, and this bullish momentum is likely to persist.

The KDJ Golden Cross occurs when the fast-moving K-line crosses above the J-line, traditionally signaling bullish sentiment. This is often seen as a strong buy signal, as it indicates that the short-term moving average is crossing above the long-term moving average. The Bullish Marubozu candlestick pattern, characterized by a long body with no shadows above or below, reinforces this bullish momentum, indicating strong buying pressure [1].

Historical backtesting of similar technical setups has shown a 68% success rate in sustaining upward trends over three trading days, with average gains of 1.2% during the period. While these technical indicators provide insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.

Marcus & Millichap's recent financial performance and strategic initiatives may also contribute to its upward trajectory. The company's focus on expanding its educational services and leveraging technology to enhance learning experiences could drive future growth. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: - Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. - Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. - CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. - Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. - Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. - Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. - JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. - Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. - Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. - MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. - Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. - Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. - Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. - Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. - Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. - Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. - Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. - Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. - PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. - Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].

Investors should closely monitor Marcus & Millichap's trajectory, particularly the pace of adoption for its educational services and the realization of operational efficiencies from technology investments. As of July 2, 2025, Marcus & Millichap's stock price shows strong bullish momentum, suggesting potential for further price appreciation.

References:
[1] https://www.ainvest.com/news/regional-management-15min-chart-triggers-bollinger-bands-expansion-bullish-marubozu-candle-2509-13/
[2] https://www.ainvest.com/news/independent-15-min-chart-triggers-kdj-golden-cross-bullish-marubozu-pattern-emerges-2508-28/
[3] https://www.ainvest.com/news/viking-15-minute-chart-sees-kdj-golden-cross-bullish-marubozu-pattern-2508/
[4] https://www.ainvest.com/news/automatic-data-processing-sees-kdj-golden-cross-bullish-momentum-15min-chart-2508-72/